Viltepso
Chemical Name | viltolarsen |
Dosage Form | Injection (intravenous; 250 mg/5 mL, 50 mg/mL) |
Drug Class | Oligonucleotides |
System | Musculoskeletal |
Company | NS Pharma Inc. |
Approval Year | 2020 |
Indication
- For the treatment of Duchenne muscular dystrophy (DMD) in patients amenable to exon 53 skipping